SUN PHARMACEUTICAL INDUSTRIES LTD. |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 1.502 INR | -1,28% |
|
+1,18% | +19,27% |
Attività
- farmaci generici e OTC (94%): per il trattamento di malattie cardiologiche, psichiatriche, neurologiche, gastroenterologiche, diabetiche e respiratorie;
- altri (6%): principalmente ingredienti farmaceutici attivi.
Alla fine di marzo 2021, il Gruppo aveva 44 stabilimenti di produzione in tutto il mondo.
Le vendite nette sono distribuite geograficamente come segue: India (33%), Stati Uniti (31,3%), altri (35,7%).
Numero di dipendenti: 41 000
Vendite per attività
| INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 384 264 | 100,0 % | 432 789 | 100,0 % | +12,63% |
Vendite per regione
| INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
India
32,7
%
| 134 439 | 35,0 % | 141 624 | 32,7 % | +5,34% |
United States
32,3
%
| 117 344 | 30,5 % | 139 704 | 32,3 % | +19,06% |
Emerging Markets
19,8
%
| 72 757 | 18,9 % | 85 633 | 19,8 % | +17,70% |
Rest of the World
15,2
%
| 59 726 | 15,5 % | 65 827 | 15,2 % | +10,22% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Founder | 68 | 01/01/82 | |
| Director of Finance/CFO | - | 19/06/17 | |
Anil Rao
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/22 |
Anoop Deshpande
CMP | Compliance Officer | - | 01/04/21 |
Nimish Desai
IRC | Investor Relations Contact | - | - |
Suresh Kumar Rai
HRO | Human Resources Officer | - | 07/12 |
S. Damodharan
PRN | Corporate Officer/Principal | - | - |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 01/04/07 |
| Corporate Officer/Principal | 65 | - |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
| Founder | 68 | 01/01/82 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21/05/21 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 15/06/23 |
Aalok Shanghvi
BRD | Director/Board Member | - | - |
| Director/Board Member | 67 | 01/01/94 | |
| Director/Board Member | 60 | 01/11/22 | |
| Director/Board Member | 71 | 25/05/18 | |
| Director/Board Member | 68 | 21/05/21 | |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 01/04/07 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 2 399 334 970 | 1 087 065 568 ( 45,31 %) | 0 | 45,31 % |
Partecipazioni
| Nome | Azioni | % | Valorizzazione |
|---|---|---|---|
| 29 497 813 | 78.48% | 1 248 937 402 $ | |
SCPHARMACEUTICALS INC. 6.01% | 2 167 679 | 6.01% | 10 881 749 $ |
Coordinate società
Sun Pharmaceutical Industries Ltd.
CTS No. 201 B/1, Sun House Western Express Highway
400063, Mumbai
+91 22 4324 4324
http://www.sunpharma.com
Società del gruppo
| Nome | Categoria e settore |
|---|---|
Basics GmbH
 Basics GmbH Medical DistributorsDistribution Services Part of Sun Pharmaceutical Industries Ltd., Basics GmbH is a pharmaceutical company based in Leverkusen, DE. The CEO of the private company is Hellen de Kloet. The German company distributes high-quality and medically recognized prescription drugs, covering a wide range of therapeutic indications with their generics. For more information, healthcare professionals can log in with their access data on the company's website. The company's contact information is available on their website for customer service and orders. |
Medical Distributors
|
Sun Pharma (Netherlands) BV
 Sun Pharma (Netherlands) BV Drugstore ChainsRetail Trade Sun Pharma (Netherlands) BV engages in the sale and distribution of generic medicine. The company is headquartered in Hoofddorp, the Netherlands. |
Drugstore Chains
|
Sun Pharma Distributors Ltd.
| |
Sun Pharma Laboratories Ltd.
 Sun Pharma Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Sun Pharma Laboratories Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Settore
Vendite per regione
Revisioni EPS
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| +19,27% | 43,75 Mrd | |
| +27,47% | 22,06 Mrd | |
| +15,37% | 14,46 Mrd | |
| +12,33% | 13,62 Mrd | |
| +38,36% | 11,61 Mrd | |
| -9,54% | 6,9 Mrd | |
| -0,05% | 6,79 Mrd | |
| -8,87% | 5,73 Mrd | |
| +9,64% | 5,32 Mrd | |
| -2,57% | 4,8 Mrd |
- Borsa valori
- Azioni
- Azione SUNPHARMA
- Società Sun Pharmaceutical Industries Ltd.
